Barry J. Simon's Insider Trades & SAST Disclosures
Barry J. Simon's most recent trade in ImmunityBio Inc was a trade of 15,243 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 22, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Barry J. Simon.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ImmunityBio Inc | Barry J. Simon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2025 | 15,243 | 30,488 | - | - | Restricted Stock Units | |
| ImmunityBio Inc | Barry J. Simon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2025 | 15,243 | 3,249,024 | - | 0 | Common Stock | |
| ImmunityBio Inc | Barry J. Simon | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.42 per share. | 22 Feb 2025 | 5,453 | 3,243,571 | - | 3.4 | 18,649 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 22 Jan 2025 | 110,020 | 3,233,781 | - | 2.0 | 219,864 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2025 | 110,020 | 0 | - | - | Stock Option (right to buy) | |
| Viracta Therapeutics Inc | Barry J. Simon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| ImmunityBio Inc | Barry Simon J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 159,146 | 159,146 | - | - | Stock Option (right to buy) | |
| ImmunityBio Inc | Barry J. Simon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 45,731 | 45,731 | - | - | Restricted Stock Units | |
| ImmunityBio Inc | J. Barry Simon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 57,200 | 3,145,855 | - | 0 | Common Stock | |
| ImmunityBio Inc | Barry J. Simon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 57,200 | 0 | - | - | Restricted Stock Units | |
| ImmunityBio Inc | J. Simon Barry | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.36 per share. | 31 Jan 2024 | 22,094 | 3,123,761 | - | 3.4 | 74,236 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2023 | 114,399 | 114,399 | - | - | Restricted Stock Units | |
| Viracta Therapeutics Inc | Barry J. Simon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Viracta Therapeutics Inc | Barry J. Simon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| ImmunityBio Inc | Barry J. Simon | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2021 | 71,051 | 3,031,456 | - | 0 | Common Stock | |
| ImmunityBio Inc | Barry J. Simon | Director | Sale of securities on an exchange or to another person at price $ 16.18 per share. | 21 May 2021 | 88,787 | 3,102,507 | - | 16.2 | 1,436,822 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Sale of securities on an exchange or to another person at price $ 16.02 per share. | 21 May 2021 | 21,223 | 3,191,294 | - | 16.0 | 340,071 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Sale of securities on an exchange or to another person at price $ 16.09 per share. | 21 May 2021 | 14,990 | 3,212,517 | - | 16.1 | 241,164 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.75 per share. | 05 May 2021 | 56,967 | 3,227,507 | - | 1.8 | 99,943 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 56,967 | 0 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Barry J. Simon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges